Angiotensin-Inhibiting Drugs Do Not Impact Disease Activity in Patients with Rheumatoid Arthritis: A Retrospective Cross-Sectional Study

Angiotensin-Inhibiting Drugs Do Not Impact Disease Activity in Patients with Rheumatoid Arthritis: A Retrospective Cross-Sectional Study

Objectives: Besides their proven effectivity in decreasing the risk of cardiovascular events, angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II type 1 receptor blockers (ARBs) are likely to possess anti-inflammatory properties as well. This study aims to investigate whether the use...

Full description

Bibliographic Details
Main Authors: Dorien M. C. F. Sluijsmans, Daphne C. Rohrich, Calin D. Popa, Bart J. F. van den Bemt
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Journal of Clinical Medicine
Subjects:
rheumatoid arthritis
cardiovascular
ACE inhibitors
angiotensin II receptor blockers
Online Access:https://www.mdpi.com/2077-0383/10/9/1985

Similar Items

Similar Items